USPSTF: Docs should talk with high-risk women about breast cancer drugs

09/24/2013 | Reuters

The U.S. Preventive Services Task Force has released a statement recommending that physicians talk with women at high risk of developing breast cancer about drugs that might reduce their risk. Tamoxifen or raloxifene interfere with the effects of estrogen in breast tissue, but they are associated with side effects including blood clot risk.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN